Skip to content
Surgical / MedicalHealthcare & Hospitals

R-ONE vascular surgical

Built by MicroPort MedBot (Group) · China

Updated Jul 2026·methodology
Ask Scout

The R-ONE vascular surgical is a Surgical / Medical robot developed by MicroPort MedBot (Group) (China), launched 2014. Key specifications: procedures percutaneous coronary intervention (PCI), vascular intervention, imaging compat. compatible with mainstream cath lab imaging systems, fda year false, ce mark year true.

RoboScore

32.0/ 100

Weak evidence

No confirmed deployment on record — this score reflects the rest of the record, not verified adoption.

4 of 9 signals present

Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.

Weighted factors

average of the 4 scored · blanks don't count

Commercial maturity20%25/100
Deployment footprint18%unknown
Proven track record12%unknown
Spec completeness12%87/100
Company financial health12%unknown
Company maturity8%55/100
Manufacturer portfolio6%41/100
Media mentions (trailing 12 months)6%unknown
Independent recognition4%unknown

Not in the Surgical / Medical standing. The standings cover robots first sold from 2020 onward, and this one launched in 2014. Its Robo Score above is unaffected — the score is the evidence, the standing is only who it is listed against.

See the Surgical / Medical standing

Will it fit your job?

Tell us the job in plain words — we'll show how this robot measures up, line by line.

No needs set yet

Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how R-ONE vascular surgical measures up, requirement by requirement. The RoboScore (trust) above is shown for every buyer, regardless.

Overview

The R-ONE Vascular Intervention Robot is the world's first dual-finger grasp mimic vascular intervention robot, designed for percutaneous coronary intervention (PCI). It reproduces manual operation with 0-360 degree rotating and continuous movement, millimeter stepping for precision, and one-key locking/unlocking. It received China approval in February 2024, previously CE-marked, and is the only commercialized CE-marked vascular robotic platform. In Chinese clinical trials it achieved 100% clinical and technological success in challenging cases including large angle twisted vessels, diffuse long lesions, calcified lesions, and sub-total occlusions. Compatible with mainstream interventional devices and cath labs. 5G remote PCI capability demonstrated over 2800 km in July 2023.

Flagship features

  • World's first dual-finger grasp mimic technology for vascular intervention
  • 0-360 degree continuous rotation mimicking hand gestures
  • Millimeter stepping for precise device positioning
  • One-key locking/unlocking for secured lesion access
  • 100% clinical and technological success rate in Chinese clinical trials
  • Only commercialized CE-marked vascular robotic platform

Buyer decision signals

Viability

est. 2015

DFVision imaging system received CE mark

Price

Research platform

Published figures are build cost or program budget, not a purchase price

Specifications

Category: Surgical / Medical
Procedures
percutaneous coronary intervention (PCI), vascular intervention
Imaging compat.
compatible with mainstream cath lab imaging systems
FDA year
false
CE mark year
true
VerifiedSelf-reportedEstimated

Company profile

Founded
2015

Detailed specifications

What it is built for1
Sub Category
vascular intervention

Company milestones

  • Nov 2025MilestoneDFVision imaging system received CE mark
  • Oct 2025Milestone100 global commercial orders reached
  • May 2025LaunchNMPA approval for commercial telesurgery
  • Mar 2024DeploymentR-ONE performed complex vascular procedures at NICVD
  • Feb 2024LaunchR-ONE received approval in China
  • Dec 2023LaunchR-ONE approved by NMPA for market launch
  • Jul 2023DeploymentFirst 5G ultra-remote robotic PCI with R-ONE
  • Nov 2021MilestoneHKEX listing

Frequently asked questions

Who makes the R-ONE vascular surgical?
The R-ONE vascular surgical is developed by MicroPort MedBot (Group), based in China.
What type of robot is the R-ONE vascular surgical?
The R-ONE vascular surgical is a Surgical / Medical robot made by MicroPort MedBot (Group).
How much does the R-ONE vascular surgical cost?
Pricing for the R-ONE vascular surgical is not publicly listed — contact MicroPort MedBot (Group) for a quote.
When was the R-ONE vascular surgical launched?
The R-ONE vascular surgical was launched in 2014.
What are the key specifications of the R-ONE vascular surgical?
Key specifications of the R-ONE vascular surgical: procedures percutaneous coronary intervention (PCI), vascular intervention, imaging compat. compatible with mainstream cath lab imaging systems, fda year false, ce mark year true.

Reviews for R-ONE vascular surgical

Loading reviews…

Buyers also compared this with

Related reading

Industry Knowledge →